+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Human Growth Hormone Market Size, Share & Trends Analysis Report by Application (Growth Hormone Deficiency, Turner Syndrome), by Distribution Channel, by Region, and Segment Forecasts, 2020 - 2027

  • ID: 4452009
  • Report
  • February 2020
  • Region: Global
  • 120 pages
  • Grand View Research
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Eli Lilly and Company
  • Ferring B.V.
  • Genentech, Inc.
  • Ipsen
  • Merck KGaA
  • Novo Nordisk A/S
  • MORE
The global human growth hormone market size is expected to reach a value of USD 8.5 billion by 2027, registering a CAGR of 8.2% over the forecast period according to this report. Introduction of novel therapies, increasing R&D activities, and rising awareness for the diagnosis and treatment of growth hormone (GH) disorders are expected to drive the market over the forecast period.

Key players operating in the market are involved in extensive R&D activities for the development of novel GH therapies to strengthen their position in the market. For instance, in October 2019, VISEN Pharmaceuticals, a joint venture of Denmark-based Ascendis Pharma A/S, received approval from China National Drug Administration (NMPA) for its new drug (IND) application to start Phase III clinical study of TransCon hGH. Furthermore, two South Korean companies, Genexine Inc. and Handok Inc., are conducting a Phase II clinical trial study on GX-H9, a recombinant human GH for the treatment of adult and pediatric GH deficiency.

Furthermore, increase in the number of regulatory approvals and launch of novel hGH therapies are expected to fuel the market over the forecast period. For instance, in January 2018, Ferring Pharmaceuticals Inc., a Switzerland-based pharmaceutical company, received United States Food and Drug Administration (USFDA) approval for its new recombinant hGH, Zomacton (somatropin) indicated for the treatment of adult patients with GH deficiency.

Various government and private organizations have been undertaking initiatives and programs to spread awareness about GH deficiency and facilitate timely diagnosis and treatment. Nonprofit organizations such as Human Growth Foundation are engaged in providing research support and spreading awareness about GH deficiency and its treatment. Such initiatives are expected to drive the demand for hGH treatment therapies.

Further key findings from the study suggest:
  • GH deficiency was the largest application segment in 2019 owing to increase in regulatory approvals and launch of novel therapies
  • Rising awareness about GH deficiency, coupled with increasing hospital visits for its treatment, is expected to drive the hospital distribution channel segment
  • North America dominated the human growth hormone market with the largest share in 2019. This is attributed to favorable reimbursement scenario, high awareness, and the presence of major players in the region
  • Asia Pacific is projected to witness a lucrative CAGR over the forecast period owing to increasing penetration of key players with their new growth hormone therapies
  • The key players include Novo Nordisk A/S, Pfizer Inc., Eli Lilly and Company, Sandoz International GmbH (Novartis AG), Merck KGaA, Genentech, Inc. (Roche), Ferring Pharmaceuticals, Teva Pharmaceutical Industries, Ltd, and Ipsen.

Please note: This product will be delivered within 48 business hours after receipt of order.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Eli Lilly and Company
  • Ferring B.V.
  • Genentech, Inc.
  • Ipsen
  • Merck KGaA
  • Novo Nordisk A/S
  • MORE
Chapter 1 Methodology and Scope
1.1 Market segmentation & scope
1.2 Market definition
1.3 Information procurement
1.3.1 Purchased database
1.3.2 Internal database
1.3.3 Secondary sources & third party perspectives
1.3.4 Primary research
1.4 Information analysis
1.4.1 Data analysis models
1.5 Market formulation & data visualization
1.6 Data validation & publishing

Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights

Chapter 3 Human Growth Hormone (hGH) Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Penetration and Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market driver analysis
3.3.1.1 Increasing R&D investments
3.3.1.2 Introduction of novel therapies
3.3.1.3 Increasing awareness regarding GH deficiency
3.3.1.4 Robust pipeline
3.3.1.5 Strategic initiatives by key players
3.3.2 Market Restraint Analysis
3.3.2.1 Adverse effects related to hormone therapies
3.3.2.2 Stringent regulatory scenario
3.3.2.3 High treatment cost
3.3.3 Industry challenges
3.4 Human Growth Hormone (hGH) Market Analysis Tools
3.4.1 Industry analysis – Porter’s
3.4.1.1 Supplier Power
3.4.1.2 Buyer Power
3.4.1.3 Substitution Threat
3.4.1.4 Threat from new entrants
3.4.1.5 Competitive Rivalry
3.4.2 PESTEL Analysis
3.4.2.1 Political Landscape
3.4.2.2 Environmental Landscape
3.4.2.3 Social landscape
3.4.2.4 Technology landscape
3.4.2.5 Legal Landscape
3.4.3 Major deals and strategic alliances analysis
3.4.3.1 Joint ventures
3.4.3.2 Mergers and acquisitions
3.4.3.3 Licensing and partnership
3.4.3.4 Technology collaborations
3.4.3.5 Strategic Divestments
3.4.4 Market entry strategies

Chapter 4 Human Growth Hormone (hGH) Market - Competitive Analysis
4.1 Recent Developments & Impact Analysis, by Key Market Participants
4.2 Vendor Landscape
4.2.1 List of key distributors and channel partners
4.2.2 Key company market share analysis, 2019
4.3 Public Companies
4.3.1 Company market position analysis
4.3.2 Competitive dashboard analysis
4.4 Private Companies
4.4.1 List of key emerging companies
4.4.2 Regional network map
4.4.3 Company market position analysis

Chapter 5 Human Growth Hormone (hGH) Market: Application Estimates And Trend Analysis
5.1 Definition & Scope
5.2 Application Market Share Analysis, 2019 & 2027
5.3 Segment Dashboard
5.4 Global Human Growth Hormone (hGH) Market, by Application, 2016 to 2027
5.5 Market Size & Forecasts and Trend Analyses, 2016 to 2027
5.5.1 Growth Hormone Deficiency
5.5.1.1 Growth Hormone Deficiency Market Estimates and Forecasts, 2016 to 2027 (USD Million)
5.5.1.2 Adult Growth Hormone Deficiency
5.5.1.2.1 Adult Growth Hormone Deficiency Market Estimates and Forecasts, 2016 to 2027 (USD Million)
5.5.1.3 Pediatric Growth Hormone Deficiency
5.5.1.3.1 Pediatric Growth Hormone Deficiency Market Estimates and Forecasts, 2016 to 2027 (USD Million)
5.5.2 Turner Syndrome
5.5.2.1 Turner Syndrome Market Estimates and Forecasts, 2016 to 2027 (USD Million)
5.5.3 Idiopathic Short Stature
5.5.3.1 Idiopathic Short Stature Market Estimates and Forecasts, 2016 to 2027 (USD Million)
5.5.4 Prader-Willi Syndrome
5.5.4.1 Prader-Willi Syndrome Market Estimates and Forecasts, 2016 to 2027 (USD Million)
5.5.5 Small for Gestational Age
5.5.5.1 Small for Gestational Age Market Estimates and Forecasts, 2016 to 2027 (USD Million)
5.5.6 Others
5.5.6.1 Others Market Estimates and Forecasts, 2016 to 2027 (USD Million)

Chapter 6 Human Growth Hormone (hGH) Market: Distribution Channel Estimates And Trend Analysis
6.1 Definition & Scope
6.2 Distribution Channel Market Share Analysis, 2019 & 2027
6.3 Segment Dashboard
6.4 Global Human Growth Hormone (hGH) Market, by Distribution Channel, 2016 to 2027
6.5 Market Size & Forecasts and Trend Analyses, 2016 to 2027
6.5.1 Hospital Pharmacy
6.5.1.1 Hospital Pharmacy Market Estimates and Forecasts, 2016 to 2027 (USD Million)
6.5.2 Retail Pharmacy
6.5.2.1 Retail Pharmacy Market Estimates and Forecasts, 2016 to 2027 (USD Million)
6.5.3 Online Pharmacy
6.5.3.1 Online Pharmacy Market Estimates and Forecasts, 2016 to 2027 (USD Million)
6.5.4 Specialty Pharmacy
6.5.4.1 Specialty Pharmacy Market Estimates and Forecasts, 2016 to 2027 (USD Million)

Chapter 7 Human Growth Hormone (hGH) Market: Regional Estimates & Trend Analysis
7.1 Regional Market Snapshot
7.2 Regional Market Share and Leading Players, 2019
7.2.1 North America
7.2.2 Europe
7.2.3 Latin America
7.2.4 Asia Pacific
7.2.5 Middle East & Africa
7.3 Market Share Analysis by Country, 2019
7.3.1 North America
7.3.1.1 U.S.
7.3.1.2 Canada
7.3.2 Europe
7.3.2.1 U.K.
7.3.2.2 Germany
7.3.2.3 Spain
7.3.2.4 France
7.3.2.5 Italy
7.3.2.6 Russia
7.3.3 Latin America
7.3.3.1 Brazil
7.3.3.2 Mexico
7.3.3.3 Argentina
7.3.4 Asia Pacific
7.3.4.1 Japan
7.3.4.2 China
7.3.4.3 India
7.3.4.4 South Korea
7.3.4.5 Singapore
7.3.4.6 Australia
7.3.5 Middle East & Africa
7.3.5.1 South Africa
7.3.5.2 Saudi Arabia
7.3.5.3 UAE
7.4 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
7.4.1 North America
7.4.2 Europe
7.4.3 Latin America
7.4.4 Asia Pacific
7.4.5 Middle East & Africa
7.5 Market Size & Forecasts, and Trend Analysis, 2019 to 2027
7.5.1 North America
7.5.1.1 North America Market Size & Forecasts and Trend Analysis, 2016 to 2027 (USD Million)
7.5.1.2 U.S.
7.5.1.2.1 U.S. Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
7.5.1.2.2 U.S. Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
7.5.1.3 Canada
7.5.1.3.1 Canada Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
7.5.1.3.2 Canada Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
7.5.2 Europe
7.5.2.1 Europe Market Size & Forecasts and Trend Analysis, 2016 to 2027 (USD Million)
7.5.2.2 U.K.
7.5.2.2.1 U.K. Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
7.5.2.2.2 U.K. Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
7.5.2.3 Germany
7.5.2.3.1 Germany Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
7.5.2.3.2 Germany Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
7.5.2.4 Spain
7.5.2.4.1 Spain Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
7.5.2.4.2 Spain Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
7.5.2.5 France
7.5.2.5.1 France Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
7.5.2.5.2 France Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
7.5.2.6 Italy
7.5.2.6.1 Italy Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
7.5.2.6.2 Italy Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
7.5.2.7 Russia
7.5.2.7.1 Russia Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
7.5.2.7.2 Russia Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
7.5.3 Latin America
7.5.3.1 Latin America Market Size & Forecasts and Trend Analysis, 2016 to 2027 (USD Million)
7.5.3.2 Brazil
7.5.3.2.1 Brazil Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
7.5.3.2.2 Brazil Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
7.5.3.3 Mexico
7.5.3.3.1 Mexico Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
7.5.3.3.2 Mexico Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
7.5.3.4 Argentina
7.5.3.4.1 Argentina Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
7.5.3.4.2 Argentina Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
7.5.4 Asia Pacific
7.5.4.1 Asia Pacific Market Size & Forecasts and Trend Analysis, 2016 to 2027 (USD Million)
7.5.4.2 Japan
7.5.4.2.1 Japan Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
7.5.4.2.2 Japan Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
7.5.4.3 China
7.5.4.3.1 China Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
7.5.4.3.2 China Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
7.5.4.4 India
7.5.4.4.1 India Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
7.5.4.4.2 India Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
7.5.4.5 South Korea
7.5.4.5.1 South Korea Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
7.5.4.5.2 South Korea Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
7.5.4.6 Singapore
7.5.4.6.1 Singapore Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
7.5.4.6.2 Singapore Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
7.5.4.7 Australia
7.5.4.7.1 Australia Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
7.5.4.7.2 Australia Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
7.5.5 Middle East & Africa
7.5.5.1 Middle East & Africa Market Size & Forecasts and Trend Analysis, 2016 to 2027 (USD Million)
7.5.5.2 South Africa
7.5.5.2.1 South Africa Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
7.5.5.2.2 South Africa Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
7.5.5.3 Saudi Arabia
7.5.5.3.1 Saudi Arabia Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
7.5.5.3.2 Saudi Arabia Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
7.5.5.4 UAE
7.5.5.4.1 UAE Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
7.5.5.4.2 UAE Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)

Chapter 8 COMPANY PROFILE
8.1 Company Profiles
8.1.1 Novo Nordisk A/S
8.1.1.1 Company overview
8.1.1.2 Financial Performance
8.1.1.3 Product benchmarking
8.1.1.4 Strategic initiatives
8.1.2 Pfizer, Inc.
8.1.2.1 Company overview
8.1.2.2 Financial Performance
8.1.2.3 Product benchmarking
8.1.2.4 Strategic initiatives
8.1.3 Eli Lilly and Company
8.1.3.1 Company overview
8.1.3.2 Financial Performance
8.1.3.3 Product benchmarking
8.1.3.4 Strategic initiatives
8.1.4 Sandoz International GmbH
8.1.4.1 Company overview
8.1.4.2 Financial Performance
8.1.4.3 Product benchmarking
8.1.4.4 Strategic initiatives
8.1.5 Merck KGaA
8.1.5.1 Company overview
8.1.5.2 Financial Performance
8.1.5.3 Product benchmarking
8.1.5.4 Strategic initiatives
8.1.6 Genentech, Inc.
8.1.6.1 Company overview
8.1.6.2 Financial Performance
8.1.6.3 Product benchmarking
8.1.6.4 Strategic initiatives
8.1.7 Ferring B.V.
8.1.7.1 Company overview
8.1.7.2 Financial Performance
8.1.7.3 Product benchmarking
8.1.7.4 Strategic initiatives
8.1.8 Ipsen
8.1.8.1 Company overview
8.1.8.2 Financial Performance
8.1.8.3 Product benchmarking
8.1.8.4 Strategic initiatives
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Novo Nordisk A/S
  • Pfizer, Inc.
  • Eli Lilly and Company
  • Sandoz International GmbH
  • Merck KGaA
  • Genentech, Inc.
  • Ferring B.V.
  • Ipsen
Note: Product cover images may vary from those shown
Adroll
adroll